← All organizations

Melanoma Institute Australia

Academic/HospitalWebsite ↗

Also known as: Melanoma Institute Australia | Melanoma Instiute Australia | Sydney Melanoma Unit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Dec 31, 2025

Timeline

1980s

Jan 1, 1982
Melanoma Institute Australia— Founded

Drugs by trial phase (16 distinct, 18 trials)

Phase 4 (1 own, 0 via acquisition)

trametinib

Phase 3 (1 own, 0 via acquisition)

imiquimod

Phase 2 (14 own, 0 via acquisition)

Indications

Studied for

Recent trials (33)

NCT06999980Lead sponsorPhase 2Dec 31, 2025
NCT06999980OfficialPhase 2Dec 31, 2025
NCT06288191Lead sponsorPhase 2Jul 31, 2024
NCT06288191OfficialPhase 2Jul 31, 2024
NCT06151236Lead sponsorPhase 2Feb 29, 2024
NCT06151236OfficialPhase 2Feb 29, 2024
NCT05418972OfficialPhase 2Dec 31, 2022
NCT05418972Lead sponsorPhase 2Dec 31, 2022
NCT05418972Overall official - principal investigatorPhase 2Dec 31, 2022
NCT05545969Lead sponsorPhase 2Oct 31, 2022
NCT05545969Overall official - principal investigatorPhase 2Oct 31, 2022
NCT05234437Overall official - principal investigatorPhase 2Mar 9, 2022
NCT04834973Overall official - principal investigatorPhase 1/Phase 2May 7, 2021
NCT04207086Study directorPhase 2Mar 1, 2020
NCT04207086Lead sponsorPhase 2Mar 1, 2020

Details

Founded: Wollstonecraft, AU Jan 1, 1982
Last known activity: Dec 31, 2025